Archives

  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Dr Blanchard declares travel and accommodation fees from

    2019-11-11


    Dr. Blanchard declares travel and accommodation fees from Janssen Pharmaceuticals and Dr. O’Neil de-clares personal fees from Ipsen outside the submitted work. Dr. Neugut receives consultant fees from Otsuka Pharmaceuticals, United Biosource Corp, Hospira, and Eisai and EHE International. All other authors declare no conflict of interest.
    Ethical approval: Ethics approval was obtained from the University of Witwatersrand, Human Research Ethics Committee (Medical) (Certificate M160118 dated 24/02/2016) and from Columbia University (IRB protocol number AAAQ7954 dated 17/03/2016) before the commencement of this K 252a study.
    References
    2. Jeurkar N, Farrington S, Craig TR, et al. Which hospice patients with cancer are able to die in the setting of their choice? Results of a retrospective cohort study. J Clin Oncol 2012;30:2783e2787.
    3. Beccaro M, Costantini M, Rossi PG, et al. Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Community Health 2006;60:412e416.
    5. Downing J, Gomes B, Gikaara N, et al. Public prefer-ences and priorities for end-of-life care in Kenya: a population-based street survey. BMC Palliat Care 2014;13:4.
    7. Gu X, Cheng W, Cheng M, Liu M, Zhang Z. The prefer-ence of place of death and its predictors among terminally ill patients with cancer and their caregivers in China. Am J Hosp Palliat Care 2015;32:835e840.
    8. Gysels M, Pell C, Straus L, Pool R. End of life care in sub-Saharan Africa: a systematic review of the qualitative litera-ture. BMC Palliat Care 2011;10:6.
    9. O’Neil DS, Prigerson HG, Mmoledi K, et al. Informal caregiver challenges for advanced cancer patients during end-of-life care in Johannesburg, South Africa and distinc-tions based on place of death. J Pain Symptom Manage 2018;56:98e106.
    10. Gomes B, Higginson IJ. Factors influencing death at home in terminally ill patients with cancer: systematic review. BMJ 2006;332:515e521.
    11. Alonso-Babarro A, Breura E, Varela-Cerdeira M, et al. Can carpals patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol 2011;29:1159e1167.
    12. De Roo ML, Miccinesi G, Onwuteaka-Philipsen BD, et al. Actual and preferred place of death of home-dwelling 
    patients in four European countries: making sense of quality indicators. PLoS One 2014;9:e93762.
    13. Anteneh A, Araya T, Misganaw A. Factors associated with place of death in Addis Ababa, Ethiopia. BMC Palliat Care 2013;12:14.
    15. Cardenas-Turanzas M, Carrillo MT, Tovalı´n-Ahumada H, Elting L. Factors associated with place of death of cancer pa-tients in the Mexico City Metropolitan area. Support Care Cancer 2007;15:243e249.
    16. Rutstein SO, Johnson K. The DHS wealth index. DHS Comparative Reports No 6. Calverton, Maryland, USA: ORC Macro, 2004. Available from https://dhsprogram. com/publications/publication-CR6-Comparative-Reports. cfm. Accessed July 6, 2018.
    17. Harding R, Selman L, Agupio G, et al. Validation of a core outcome measure for palliative care in Africa: the APCA African palliative Outcome scale. Health Qual Life Outcomes 2010;8:10.
    18. Harding R, Selman L, Simms VM, et al. How to analyze palliative care outcome data for patients in sub-Saharan Af-rica: an international, multicenter, factor analytic examina-tion of the APCA African POS. J Pain Symptom Manage 2013;45:746e752.
    19. Epstein AS, Prigerson HG, O’Reilly EM, Maciejewski PK. Discussions of life expectancy and changes in illness under-standing in patients with advanced cancer. J Clin Oncol 2016;34:2398e2403.
    20. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377e381.